Inhibition of the mixed lymphocyte culture response by antibody following successful human renal transplantation.
D000017:ABO Blood-Group System; D000328:Adult; D000906:Antibodies; D001062:Appendectomy; D001379:Azathioprine / Q000627:therapeutic use; D002848:Chromatography, DEAE-Cellulose; D003404:Creatinine / Q000097:blood; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D005921:Glomerulonephritis / Q000601:surgery; D006650:Histocompatibility Testing; D006801:Humans; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G / Q000302:isolation & purification; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D007959:Lymphocyte Culture Test, Mixed; D008214:Lymphocytes / Q000528:radiation effects; D008775:Methylprednisolone / Q000627:therapeutic use; D009392:Nephrectomy; D013156:Splenectomy; D013936:Thymidine / Q000378:metabolism; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014316:Tritium
D000017:ABO Blood-Group System; D000906:Antibodies; D007074:Immunoglobulin G; D014316:Tritium; D003404:Creatinine; D001379:Azathioprine; D013936:Thymidine; D008775:Methylprednisolone